USE OF PROCEEDS
We estimate that the net proceeds from our issuance and sale of 30,000,000 shares of common stock in this offering, after deducting
underwriting discounts and commissions and estimated offering expenses payable by us, will be approximately $225.0 million (or approximately $258.7 million if the underwriters exercise their option to purchase additional shares in full), based on
the assumed public offering price of $7.82 per share (the closing price of our common stock on September 9, 2013).
We expect to use
the net proceeds of this offering for general corporate purposes, which we expect to include funding working capital and growth initiatives. At this time, we have not specifically identified a large single use for which we intend to use the net
proceeds, and, accordingly, we are not able to allocate the net proceeds among any potential uses in light of the variety of factors that will impact how such net proceeds will ultimately be utilized by us. As a result, our management will retain
broad discretion over the use of the net proceeds from this offering.
Pending use of the proceeds from this offering, we intend to invest
the proceeds in short-term, investment-grade and interest-bearing instruments or money market funds.